Lys Therapeutics raises over $27m to advance new treatments for Parkinson’s and stroke

Lys Therapeutics, based in Lyon and Caen, France, has raised more than €25 million since its 2021 founding. The financing package includes a grant of more than $5 million from The Michael J. Fox Foundation for Parkinson’s Research, with additional support from Bpifrance, France 2030 and private inve…

View Post on Scour ↗

More from longevity.technology on Scour.